Docking Studies and Biological Evaluation of a Potential β-Secretase Inhibitor of 3-Hydroxyhericenone F from Hericium erinaceus

Alzheimer’s disease (AD) is the most common neurodegenerative disorder, affecting approximately more than 5% of the population worldwide over the age 65, annually. The incidence of AD is expected to be higher in the next 10 years. AD patients experience poor prognosis and as a consequence new drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Diling, Chen, Tianqiao, Yong, Jian, Yang, Chaoqun, Zheng, Ou, Shuai, Yizhen, Xie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427148/
https://www.ncbi.nlm.nih.gov/pubmed/28553224
http://dx.doi.org/10.3389/fphar.2017.00219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427148/
https://www.ncbi.nlm.nih.gov/pubmed/28553224
http://dx.doi.org/10.3389/fphar.2017.00219

Ejemplares similares